{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:12:49Z","timestamp":1787699569418,"version":"build-2784847793"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.jconrel.2015.09.024","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T02:51:55Z","timestamp":1442371915000},"page":"300-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Validation of the IntelliCap\u00ae system as a tool to evaluate extended release profiles in human GI tract using metoprolol as model drug"],"prefix":"10.1016","volume":"217","author":[{"given":"Erik","family":"S\u00f6derlind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Abrahamsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3176-1078","authenticated-orcid":false,"given":"Fredrik","family":"Erlandsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ventzeslav","family":"Iordanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"von Corswant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.09.024_bb0005","series-title":"Screening oral modified release formulations in pharmaceutical industry in Oral Drug Absorption: prediction and assessment","author":"Abrahamsson","year":"2010"},{"key":"10.1016\/j.jconrel.2015.09.024_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","article-title":"In vivo methods for drug absorption \u2014 comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects","volume":"57","author":"Sj\u00f6gren","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2015.09.024_bb0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/mp800261a","article-title":"Absorption in humans: implications for early CR candidate assessment","volume":"6","author":"Tannergren","year":"2009","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.jconrel.2015.09.024_bb0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ejps.2007.01.005","article-title":"A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: experiences from 13 phase I studies","volume":"30","author":"Nyberg","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2015.09.024_bb0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i6.10","article-title":"Remote controlled capsules in human drug absorption (HDA) studies","volume":"20","author":"Wilding","year":"2003","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"3","key":"10.1016\/j.jconrel.2015.09.024_bb0030","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.gie.2013.03.170","article-title":"A novel ingestible electronic drug delivery and monitoring device","volume":"78","author":"van der Schaar","year":"2013","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.jconrel.2015.09.024_bb0035","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-014-0172-1","article-title":"Novel orally swallowable IntelliCap(\u00ae) device to quantify regional drug absorption in human GI tract using diltiazem as model drug","author":"Becker","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2015.09.024_bb0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-5173(91)90139-F","article-title":"Influence of dissolution rate on the extent and rate of bioavailability of metoprolol","volume":"68","author":"Sandberg","year":"1991","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2015.09.024_bb0045","first-page":"183","article-title":"Intraluminal pH of the human gastrointestinal tract","volume":"46","author":"Fallingborg","year":"1999","journal-title":"Dan. Med. Bull."},{"issue":"8","key":"10.1016\/j.jconrel.2015.09.024_bb0050","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2015.09.024_bb0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3109\/03639048709068677","article-title":"Development of a new controlled release metoprolol product","volume":"13","author":"Ragnarsson","year":"1987","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2015.09.024_bb0060","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01061407","article-title":"Pharmacokinetic studies on the selective \u03b11-receptor antagonist metoprolol in man","volume":"2","author":"Regardh","year":"1974","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"5","key":"10.1016\/j.jconrel.2015.09.024_bb0065","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1021\/ci0102822","article-title":"Estimating the water solubilities of crystalline compounds from their chemical structures alone","volume":"41","author":"McFarland","year":"2001","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.jconrel.2015.09.024_bb0070","first-page":"1166","article-title":"Numerical convolution\/deconvolution as a tool for correlating in vitro with in vivo drug availability","volume":"44","author":"Langenbucher","year":"1982","journal-title":"Pharm. Ind."},{"key":"10.1016\/j.jconrel.2015.09.024_bb0075","series-title":"Guidance for Industry Extended Release Oral Dosage Forms: Development, Evaluation, and Application of in vitro\/in vivo Correlations, Food and Drug Administration","year":"1997"},{"key":"10.1016\/j.jconrel.2015.09.024_bb0080","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.27.8.886","article-title":"Transit of pharmaceutical dosage forms through the small intestine","volume":"27","author":"Davis","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2015.09.024_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0378-5173(96)04604-2","article-title":"A clinical single-pass perfusion gastro-intestinal transit of a multiple-unit formulation (metoprolol CR\/ZOK) and a non-disintegrating tablet with the emphasis on colon","volume":"140","author":"Abrahamsson","year":"1996","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.jconrel.2015.09.024_bb0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cgh.2009.01.017","article-title":"Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation","volume":"7","author":"Rao","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2015.09.024_bb0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0168-3659(90)90143-H","article-title":"A structured approach for development of a controlled release drug delivery system for a beta-adrenoceptor blocking drug","volume":"11","author":"John","year":"1990","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.09.024_bb0100","series-title":"CRS 41st annual meeting","article-title":"Development and Operation of a New IntelliCap\u00ae Fast Release System","author":"Kerkhof","year":"2014"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365915301255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T19:24:31Z","timestamp":1556306671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365915301255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":20,"alternative-id":["S0168365915301255"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.024","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the IntelliCap\u00ae system as a tool to evaluate extended release profiles in human GI tract using metoprolol as model drug","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}